Sorafenib treatment of FLT3-ITD( ) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation. (Q27851723)
Jump to navigation
Jump to search
scientific article
- Sorafenib treatment of FLT3-ITD( ) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib treatment of FLT3-ITD( ) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation. |
scientific article |
|
Statements
2 references
Sorafenib treatment of FLT3-ITD( ) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation (English)
Cheuk Him Man
Tsz Kan Fung
Christa Ho
Heron H C Han
Howard C H Chow
William W L Choi
Si Lok
Alice M S Cheung
Yok Lam Kwong
Anskar Y H Leung
24 February 2012
Identifiers
2 references
2 references